ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,288, issued on Dec. 16, was assigned to Gedea Biotech AB (Lund, Sweden).
"Vaginal tablet formulation" was invented by Ulf Ellervik (Loddekopinge, Sweden), Sophie Manner (Helsingborg, Sweden), Olov Sterner (Malmo, Sweden), Helena Strevens (Lund, Sweden), Nils-Olof Lindberg (Limhamn, Sweden) and Annette Safholm (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns a pharmaceutical composition comprising glucono-Delta-lactone, which is suitable for use in the treatment of vaginal microbial infections."
The patent was filed on April 3, 2020, under Application No. 17/601,521.
*For further information, including ima...